Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-24-000175
Filing Date
2024-02-14
Accepted
2024-02-14 11:10:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 ovid13ga-02142024.htm SC 13G/A 102115
  Complete submission text file 0001013594-24-000175.txt   103694
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90350 | Film No.: 24634195
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155
Business Address 150 EAST 58TH STREET 14TH FLOOR NEW YORK NY 10155 212-702-8644
Madison Avenue Partners, LP (Filed by) CIK: 0001801265 (see all company filings)

EIN.: 320567414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A